XML 54 R41.htm IDEA: XBRL DOCUMENT
v3.24.3

Shares and Stockholders’ Equity (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2024
Stockholders' Equity Note [Abstract] |
Schedule of Changes in Preferred | Preferred stock authorized, issued and outstanding (number of shares) was as follows:
| As of September 30, 2024 |  | As of December 31, 2023
| Shares Authorized |  | Shares Issued |  | Shares Outstanding |  | Shares Authorized |  | Shares Issued |  | Shares Outstanding
9.250% Fixed Rate Reset Non-Cumulative |  |  |  |  |  |  |  |  |  |  |
Preferred Stock, Series C | 20,000 |  |  | 20,000 |  |  | 20,000 |  |  | 20,000 |  |  | 20,000 |  |  | 20,000 |
9.000% Non-Cumulative Preferred Stock, Series D | 20,000 |  |  | 20,000 |  |  | 20,000 |  |  | 20,000 |  |  | 20,000 |  |  | 20,000 |
Not designated | 9,960,000 |  |  | – |  |  | – |  |  | 9,960,000 |  |  | – |  |  | – |
Total preferred shares | 10,000,000 |  |  | 40,000 |  |  | 40,000 |  |  | 10,000,000 |  |  | 40,000 |  |  | 40,000 |
The per share and aggregate dividends declared for preferred stock by series (in millions except per share data) was as follows:
| For the Three Months Ended September 30,
| 2024 |  | 2023
| Dividend |  | Aggregate |  | Dividend |  | Aggregate
Series | Per Share |  | Dividend |  | Per Share |  | Dividend
Series C | $ | 1,156.25 |  |  | $ | 23 |  |  | $ | 1,156.25 |  |  | $ | 23 |
Series D | 562.50 |  |  | 11 |  |  | 562.50 |  |  | 11 |
Total | $ | 1,718.75 |  |  | $ | 34 |  |  | $ | 1,718.75 |  |  | $ | 34 |
|  | For the Nine Months Ended September 30,
|  | 2024 |  |  | 2023
|  | Dividend |  |  | Aggregate |  |  | Dividend |  |  | Aggregate
Series |  | Per Share |  |  | Dividend |  |  | Per Share |  |  | Dividend
Series C |  | $ | 2,312.50 |  |  |  | $ | 46 |  |  |  | $ | 1,792.19 |  |  |  | $ | 36 |
Series D |  | 1,687.50 |  |  |  | 34 |  |  |  | 1,743.75 |  |  |  | 35 |
Total |  | $ | 4,000.00 |  |  |  | $ | 80 |  |  |  | $ | 3,535.94 |  |  |  | $ | 71 |
Schedule of Common Stock Outstanding Roll Forward | The changes in our common stock (number of shares) were as follows:
| For the Three Months Ended September 30, |  | For the Nine Months Ended September 30,
| 2024 |  | 2023 |  | 2024 |  |  | 2023
Common Stock |  |  |  |  |  |  |  |
Balance as of beginning-of-period | 170,188,487 |  |  | 169,630,880 |  |  | 169,666,137 |  |  |  | 169,220,511 |
Stock compensation/issued for benefit plans | 152,980 |  |  | 27,391 |  |  | 675,330 |  |  |  | 437,760 |
Balance as of end-of-period | 170,341,467 |  |  | 169,658,271 |  |  | 170,341,467 |  |  |  | 169,658,271 |
Reconciliation of the Denominator Calculations of Basic and Diluted Earnings per Share | The calculation of earnings per share (“EPS”) was as follows (in millions except per share data):
| For the Three Months Ended September 30, |  |  |  | For the Nine Months Ended September 30,
| 2024 |  | 2023 |  |  |  | 2024 |  |  | 2023
Net income (loss) available to common stockholders – basic | $ | (562) |  |  | $ | 819 |  |  |  |  | $ | 1,508 |  |  |  | $ | 412 |
Net income (loss) available to common stockholders – diluted | $ | (562) |  |  | $ | 819 |  |  |  |  | $ | 1,511 |  |  |  | $ | 410 |
Weighted-average shares, as used in basic calculation | 170,773,438 |  | 169,645,881 |  |  |  | 170,482,264 |  |  | 169,529,509
Incremental common shares from assumed exercise or |  |  |  |  |  |  |  |  |  |
issuance of stock-based incentive compensation awards | 2,075,432 |  | 623,039 |  |  |  | 1,575,034 |  |  | 507,752
Average deferred compensation shares | — |  | 621,582 |  |  |  | 710,256 |  |  | 588,183
Weighted-average shares, as used in diluted calculation (1) | 172,848,870 |  | 170,890,502 |  |  |  | 172,767,554 |  |  | 170,625,444
Net income (loss) per share: |  |  |  |  |  |  |  |  |  |
Basic | $ | (3.29) |  |  | $ | 4.82 |  |  |  |  | $ | 8.85 |  |  |  | $ | 2.43 |
Diluted | (3.29) |  |  | 4.79 |  |  |  |  | 8.75 |  |  |  | 2.40 |
(1) Due to reporting a net loss for the three months ended September 30, 2024, basic shares were used in the diluted EPS calculation for this period as the use of diluted shares would have resulted in a lower loss per share.
Components and Changes in AOCI | The following summarizes the components and changes in AOCI (in millions):
| For the Nine Months Ended September 30,
| 2024 |  | 2023
Unrealized Gain (Loss) on Fixed Maturity AFS Securities and Certain |  |  |
Other Investments |  |  |
Balance as of beginning-of-year | $ | (5,188) |  |  | $ | (8,916) |
Unrealized holding gains (losses) arising during the period | 1,555 |  |  | (3,405) |
Change in foreign currency exchange rate adjustment | 124 |  |  | (21) |
Change in future contract benefits and policyholder account balances, |  |  |
net of reinsurance | (382) |  |  | 27 |
Income tax benefit (expense) | (276) |  |  | 707 |
Less: |  |  |
Reclassification adjustment for gains (losses) included in net income (loss) | (163) |  |  | (1,145) |
Income tax benefit (expense) | 34 |  |  | 240 |
Balance as of end-of-period | $ | (4,038) |  |  | $ | (10,703) |
Unrealized Gain (Loss) on Derivative Instruments |  |  |
Balance as of beginning-of-year | $ | 375 |  |  | $ | 388 |
Unrealized holding gains (losses) arising during the period | 305 |  |  | 231 |
Change in foreign currency exchange rate adjustment | (121) |  |  | 30 |
Income tax benefit (expense) | (39) |  |  | (55) |
Less: |  |  |
Reclassification adjustment for gains (losses) included in net income (loss) | 60 |  |  | 68 |
Income tax benefit (expense) | (13) |  |  | (14) |
Balance as of end-of-period | $ | 473 |  |  | $ | 540 |
Market Risk Benefit Non-Performance Risk Gain (Loss) |  |  |
Balance as of beginning-of-year | $ | 1,070 |  |  | $ | 1,741 |
Adjustment arising during the period | (367) |  |  | (944) |
Income tax benefit (expense) | 78 |  |  | 202 |
Balance as of end-of-period | $ | 781 |  |  | $ | 999 |
Policyholder Liability Discount Rate Remeasurement Gain (Loss) |  |  |
Balance as of beginning-of-year | $ | 587 |  |  | $ | 747 |
Adjustment arising during the period | (209) |  |  | 347 |
Income tax benefit (expense) | 44 |  |  | (73) |
Balance as of end-of-period | $ | 422 |  |  | $ | 1,021 |
Foreign Currency Translation Adjustment |  |  |
Balance as of beginning-of-year | $ | (26) |  |  | $ | (34) |
Foreign currency translation adjustment arising during the period | 8 |  |  | 1 |
Balance as of end-of-period | $ | (18) |  |  | $ | (33) |
Funded Status of Employee Benefit Plans |  |  |
Balance as of beginning-of-year | $ | (294) |  |  | $ | (278) |
Adjustment arising during the period | (8) |  |  | (26) |
Balance as of end-of-period | $ | (302) |  |  | $ | (304) |
Schedule of Reclassifications Out of AOCI | The following summarizes the reclassifications out of AOCI (in millions) and the associated line item on the Consolidated Statements of Comprehensive Income (Loss):
| For the Nine Months Ended September 30, |
| 2024 |  | 2023 |
Unrealized Gain (Loss) on Fixed Maturity AFS |  |  |  |
Securities and Certain Other Investments |  |  |  |
Reclassification | $ | (193) |  |  | $ | (1,175) |  | Realized gain (loss)
Associated change in future contract benefits | 30 |  |  | 30 |  | Benefits
Reclassification before income tax benefit (expense) | (163) |  |  | (1,145) |  | Income (loss) before taxes
Income tax benefit (expense) | 34 |  |  | 247 |  | Federal income tax expense (benefit)
Reclassification, net of income tax | $ | (129) |  |  | $ | (898) |  | Net income (loss)
Unrealized Gain (Loss) on Derivative Instruments |  |  |  |
Interest rate contracts | (2) |  |  | – |  | Net investment income
Interest rate contracts | 20 |  |  | 22 |  | Interest and debt expense
Foreign currency contracts | 41 |  |  | 42 |  | Net investment income
Foreign currency contracts | 1 |  |  | 4 |  | Realized gain (loss)
Reclassifications before income tax benefit (expense) | 60 |  |  | 68 |  | Income (loss) before taxes
Income tax benefit (expense) | (13) |  |  | (14) |  | Federal income tax expense (benefit)
Reclassifications, net of income tax | $ | 47 |  |  | $ | 54 |  | Net income (loss)

X
- Definition Disclosure in tabular form of the changes in the number of shares of the entity's preferred and common stock during the reporting period. + References No definition available. + Details
Name: | lnc_ScheduleOfChangesInPreferredTableTextBlock
Namespace Prefix: | lnc_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss). + References No definition available. + Details
Name: | us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of accumulated other comprehensive income (loss). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 14A -Publisher FASB -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20 + Details
Name: | us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the change in common stock outstanding. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration